Sio Capital Management, LLC Mersana Therapeutics, Inc. Transaction History

Sio Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $1.35 Million - $2.28 Million	-157,259 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$15.31 - $26.52 $424,087 - $734,604	-27,700 Reduced 14.98%	157,259 $2.54 Million
Q4 2020 Feb 16, 2021	SELL	$16.84 - $27.59 $1.8 Million - $2.95 Million	-106,822 Reduced 36.61%	184,959 $4.92 Million
Q3 2020 Nov 16, 2020	SELL	$16.2 - $25.7 $1.3 Million - $2.06 Million	-80,000 Reduced 21.52%	291,781 $5.43 Million
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $1.08 Million - $4.81 Million	205,531 Added 123.63%	371,781 $8.7 Million
Q4 2019 Feb 14, 2020	BUY	$1.45 - $6.73 $241,062 - $1.12 Million	166,250 New	166,250 $953,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.